Amer El Ghali

549 total citations · 1 hit paper
14 papers, 326 citations indexed

About

Amer El Ghali is a scholar working on Molecular Medicine, Pharmacology and Ecology. According to data from OpenAlex, Amer El Ghali has authored 14 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Medicine, 8 papers in Pharmacology and 5 papers in Ecology. Recurrent topics in Amer El Ghali's work include Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Bacteriophages and microbial interactions (5 papers). Amer El Ghali is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Bacteriophages and microbial interactions (5 papers). Amer El Ghali collaborates with scholars based in United States. Amer El Ghali's co-authors include Ashlan J. Kunz Coyne, Dana Holger, Nicholas Rebold, Michael J. Rybak, Michael J. Rybak, Razieh Kebriaei, Kyle Stamper, Michael P. Veve, Susan M. Lehman and Taylor Morrisette and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Antibiotics.

In The Last Decade

Amer El Ghali

14 papers receiving 317 citations

Hit Papers

Therapeutic Strategies fo... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amer El Ghali United States 9 171 111 92 71 69 14 326
Ashlan J. Kunz Coyne United States 13 214 1.3× 146 1.3× 154 1.7× 95 1.3× 85 1.2× 33 495
Matthew D. Surette Canada 7 135 0.8× 137 1.2× 51 0.6× 29 0.4× 44 0.6× 10 351
Nadal A. Al-Saryi Iraq 6 232 1.4× 160 1.4× 48 0.5× 43 0.6× 48 0.7× 13 386
Yeshimebet Kassa Ethiopia 6 226 1.3× 124 1.1× 32 0.3× 46 0.6× 49 0.7× 10 361
Javad Yasbolaghi Sharahi Iran 9 171 1.0× 149 1.3× 23 0.3× 43 0.6× 42 0.6× 17 366
Cui Zhou China 12 205 1.2× 91 0.8× 48 0.5× 22 0.3× 59 0.9× 25 325
Sabrina Royer Brazil 12 239 1.4× 131 1.2× 42 0.5× 70 1.0× 47 0.7× 19 355
Jiayue Ma China 8 161 0.9× 76 0.7× 23 0.3× 54 0.8× 40 0.6× 17 324
Vincent Trebosc Switzerland 9 308 1.8× 184 1.7× 48 0.5× 27 0.4× 81 1.2× 15 465
Ali F. Aboklaish United Kingdom 8 170 1.0× 52 0.5× 21 0.2× 41 0.6× 75 1.1× 13 282

Countries citing papers authored by Amer El Ghali

Since Specialization
Citations

This map shows the geographic impact of Amer El Ghali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amer El Ghali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amer El Ghali more than expected).

Fields of papers citing papers by Amer El Ghali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amer El Ghali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amer El Ghali. The network helps show where Amer El Ghali may publish in the future.

Co-authorship network of co-authors of Amer El Ghali

This figure shows the co-authorship network connecting the top 25 collaborators of Amer El Ghali. A scholar is included among the top collaborators of Amer El Ghali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amer El Ghali. Amer El Ghali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ghali, Amer El, Ashlan J. Kunz Coyne, Dana Holger, et al.. (2024). Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections. Microbiology Spectrum. 12(2). e0310823–e0310823. 6 indexed citations
2.
Coyne, Ashlan J. Kunz, Amer El Ghali, Nicholas Rebold, et al.. (2023). High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open Forum Infectious Diseases. 10(3). ofad034–ofad034. 15 indexed citations
3.
Rebold, Nicholas, Abdalhamid M Lagnf, Sara Alosaimy, et al.. (2023). Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum. 11(1). e0264722–e0264722. 14 indexed citations
4.
Ghali, Amer El, et al.. (2023). Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(6). 502–513. 29 indexed citations
5.
Ghali, Amer El, et al.. (2023). 2118. Comparative Analysis of Cefiderocol Mono- and Combination Therapy for Multi-Drug Resistant Gram-negative Infections. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations
6.
Holger, Dana, Amer El Ghali, Katherine L. Lev, et al.. (2023). Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models. Antimicrobial Agents and Chemotherapy. 67(11). e0057823–e0057823. 18 indexed citations
7.
Coyne, Ashlan J. Kunz, Kyle Stamper, Amer El Ghali, et al.. (2023). Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model. Microbiology Spectrum. 11(4). e0034023–e0034023. 12 indexed citations
8.
Ghali, Amer El, Kyle Stamper, Ashlan J. Kunz Coyne, et al.. (2023). Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models. Antimicrobial Agents and Chemotherapy. 67(11). e0072823–e0072823. 6 indexed citations
9.
Kebriaei, Razieh, Susan M. Lehman, Kyle Stamper, et al.. (2023). Optimization of Phage-Antibiotic Combinations against Staphylococcus aureus Biofilms. Microbiology Spectrum. 11(3). e0491822–e0491822. 28 indexed citations
10.
11.
Coyne, Ashlan J. Kunz, Amer El Ghali, Dana Holger, Nicholas Rebold, & Michael J. Rybak. (2022). Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious Diseases and Therapy. 11(2). 661–682. 162 indexed citations breakdown →
12.
Coyne, Ashlan J. Kunz, Kyle Stamper, Razieh Kebriaei, et al.. (2022). Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility. Antibiotics. 11(9). 1175–1175. 21 indexed citations
13.
Ghali, Amer El, Amer El Ghali, Taylor Morrisette, et al.. (2022). 1422. A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations
14.
Carr, Amy, et al.. (2020). 1270. Early Real-world Evidence in the Use of Eravacycline for the Management of Draconian Infections. Open Forum Infectious Diseases. 7(Supplement_1). S651–S652. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026